Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolin

Showing results (351-360 of 359) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 359 results.
Physical Review Letters|February 2, 2013
Entanglement of two superconducting qubits in a waveguide cavity via monochromatic two-photon excitationS Poletto, Jay M Gambetta, Seth T Merkel, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Mutant alcohol dehydrogenase leads to improved ethanol tolerance in Clostridium thermocellumSteven D Brown, Adam M Guss, Tatiana V Karpinets, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 28, 2022
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and EtoposideMartin Reck, Tony S K Mok, Aaron Mansfield, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
Engineering titania nanostructure to tune and improve its photocatalytic activityMatteo Cargnello, Tiziano Montini, Sergey Y Smolin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti-Programmed Cell Death Protein 1 or Anti-Programmed Cell Death Ligand 1 Plus Platinum ChemotherapyNatasha B Leighl, Luis Paz-Ares, Delvys Rodriguez Abreu, et al.
Lung Cancer (Amsterdam, Netherlands)|November 6, 2023
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposideStephen V Liu, Tony S K Mok, Barzin Y Nabet, et al.
Ebiomedicine|October 12, 2024
Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinomaLoic Verlingue, Antoine Italiano, Hans Prenen, et al.
JAMA Oncology|April 10, 2020
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical TrialNaiyer A Rizvi, Byoung Chul Cho, Niels Reinmuth, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2025
Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancerK Laktionov, A Smolin, D Stroyakovskiy, et al.
Pageof 36

Showing results (351-360 of 359) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 359 results.
Physical Review Letters|February 2, 2013
Entanglement of two superconducting qubits in a waveguide cavity via monochromatic two-photon excitationS Poletto, Jay M Gambetta, Seth T Merkel, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Mutant alcohol dehydrogenase leads to improved ethanol tolerance in Clostridium thermocellumSteven D Brown, Adam M Guss, Tatiana V Karpinets, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 28, 2022
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and EtoposideMartin Reck, Tony S K Mok, Aaron Mansfield, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
Engineering titania nanostructure to tune and improve its photocatalytic activityMatteo Cargnello, Tiziano Montini, Sergey Y Smolin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti-Programmed Cell Death Protein 1 or Anti-Programmed Cell Death Ligand 1 Plus Platinum ChemotherapyNatasha B Leighl, Luis Paz-Ares, Delvys Rodriguez Abreu, et al.
Lung Cancer (Amsterdam, Netherlands)|November 6, 2023
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposideStephen V Liu, Tony S K Mok, Barzin Y Nabet, et al.
Ebiomedicine|October 12, 2024
Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinomaLoic Verlingue, Antoine Italiano, Hans Prenen, et al.
JAMA Oncology|April 10, 2020
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical TrialNaiyer A Rizvi, Byoung Chul Cho, Niels Reinmuth, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2025
Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancerK Laktionov, A Smolin, D Stroyakovskiy, et al.
Pageof 36